This page lists all pharmaceutical reports related to the field of Cancer Immunotherapy. The reports include market research reports and pipeline analyses.
Displaying 101 - 150 of 159 results
- Emerging Cancer Vaccines: Forecasts, Developments and Pipeline Analysis, 4th Edition
- Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
- Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020
- Colorectal Cancer - Japan Drug Forecasts and Treatment Analysis to 2020
- Colorectal Cancer - US Drug Forecasts and Treatment Analysis to 2020
- Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
- Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017
- Colorectal Cancer - Pipeline Assessment and Market Forecasts to 2020
- Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
- US Pharmaceutical Market Outlook 2011-2021
- Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
- Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
- Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
- Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
- Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential
- Stakeholder Opinions: Melanoma
- Epidemiology: Cervical Cancer
- Pharmaceutical Key Trends 2011 – Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
- Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
- Pharmaceutical Key Trends 2011 – Biosimilar Market Overview: Biosimilar uptake set to accelerate
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
- Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth
- Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
- Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
- Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing
- Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical
- Hypopharyngeal Cancer - Pipeline Review, H2 2011
- Squamous Cell Carcinoma - Pipeline Review, H2 2011
- Osteosarcoma - Pipeline Review, H2 2011
- Pediatric Cancer - Pipeline Review, H2 2011
- Thymus Cancer - Pipeline Review, H2 2011
- Lip And Oral Cavity Cancer - Pipeline Review, H2 2011
- Carcinoma Of The Bile Duct - Pipeline Review, H2 2011
- Metastatic Brain Tumors - Pipeline Review, H2 2011
- Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- Avastin (Liver Cancer) – Analysis and Forecasts to 2020
- Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Ramucirumab (Liver Cancer) – Analysis and Forecasts to 2020
- Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2017
- Esophageal Cancer Therapeutics - Pipeline Assessment and Market Forecast to 2017
- Hodgkin Lymphoma (HL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017